Intellectual Property
Feb. 6, 2023
UC neurologist wins more than $5M from startup
According to the trial counsel, Dr. Jim Brewer was not paid stock options he was promised by the Impact executives, for his contributions to their research for a drug, fedratinib, that was on clinical hold with the Food and Drug Administration.
A trial team Ellis, George, Cipollone, O’Brien, Annaguey LLP in Los Angeles secured a jury verdict for the head of neurology at UC San Diego for more than $5 million, including punitive damages, in a dispute with a startup drug company, Impact Biomedicines, and Bristol Myers Squibb Co.
According to the trial counsel for Dr. Jim Brewer — Christopher W. Arledge and Courtney L. Mitchell — he was not paid stock options he was promised by the I...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In